Pfizer Likely To Seek US FDA Nod In September For Use Of Its COVID-19 Vaccine In Kids Aged Between 2 To 11 Years
UK: Trial Of AstraZeneca Covid-19 Vaccine On Children Paused As British Medicines' Regulator Probes Blood Clot Link
